CASE REPORT
Published on 08 Sep 2025
Posterior reversible encephalopathy syndrome after CD19 chimeric antigen receptor therapy for B-acute lymphoblastic leukemia: case report
doi 10.3389/fonc.2025.1639892
- 1,834 views
- 1 citation
- Frontiers in Oncology
- Hematologic Malignancies
- Research Topics
- Host Features Affecting CAR T Cell Therapy of Hematological Malignancies
Host Features Affecting CAR T Cell Therapy of Hematological Malignancies
2,981
Total downloads
16k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
CASE REPORT
Published on 05 Sep 2025
Successful CD19 chimeric antigen receptor T-cell therapy following autologous stem cell transplantation in a secondary central nervous system lymphoma patient with COVID-19 infection: a case report and literature review
doi 10.3389/fonc.2025.1656034
- 1,694 views
CASE REPORT
Published on 20 Aug 2025
Extramedullary relapse of acute lymphoblastic leukemia treated with a CAR-T cell therapy bridge to unrelated cord blood transplantation: a case report and review of the literature
doi 10.3389/fonc.2025.1508676
- 2,392 views
ORIGINAL RESEARCH
Published on 27 Feb 2025
Tumor gene expression signatures associated with outcome in large B−cell lymphoma treated with CD19-directed CAR T−cell therapy (axicabtagene ciloleucel)
doi 10.3389/fonc.2025.1519473
- 5,385 views
- 2 citations
CASE REPORT
Published on 05 Dec 2024
Case report: CAR-T therapy demonstrated safety and efficacy in relapsed/refractory diffuse large B-cell lymphoma patients complicated with hepatitis B-related cirrhosis
doi 10.3389/fonc.2024.1491100
- 2,292 views
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.